Inhibition of uterine contractility with various tocolytics with and without progesterone: In vitro studies

35Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: Various tocolytics are used to suppress uterine contractility in patients in preterm labor. Progesterone (P4) is used in patients at high risk for preterm delivery. In this study, we evaluated the effects of various tocolytics with and without P4 to examine effects on uterine contractility. Study Design: Uterine tissues (n = 280) from women undergoing cesarean at term were exposed in vitro to various agents (vehicle, magnesium sulfate [MgSO 4], nifedipine, indomethacin, or pinacidilall with and without P4). Contractility was measured before and after addition of the various agents. Results: P4 alone at 105 mol/L concentration has little effect to inhibit contractility (P .05). Nifedipine (108 mol/L) and indomethacin (105 mol/L) inhibit contractions alone (P

Cite

CITATION STYLE

APA

Baumbach, J., Shi, S. Q., Shi, L., Balducci, J., Coonrod, D. V., & Garfield, R. E. (2012). Inhibition of uterine contractility with various tocolytics with and without progesterone: In vitro studies. In American Journal of Obstetrics and Gynecology (Vol. 206, pp. 254.e1-254.e5). Mosby Inc. https://doi.org/10.1016/j.ajog.2011.12.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free